|
NUTM1–ZNF532
(HGNC:29919, HGNC:30940)
|
MONDO:0005563
(MONDO:0005563)
|
weak |
weak |
weak |
moderate |
weak |
|
|
MLPH–ALK
(HGNC:29643, HGNC:427)
|
MONDO:0044793
(MONDO:0044793)
|
moderate |
weak |
weak |
strong |
weak |
|
|
ACSBG1–HBG2
(HGNC:29567, HGNC:4832)
|
MONDO:0000984
(MONDO:0000984)
|
weak |
weak |
weak |
weak |
weak |
|
|
TET1–KMT2A
(HGNC:29484, HGNC:7132)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
strong |
moderate |
strong |
weak |
|
|
SPECC1L–ALK
(HGNC:29022, HGNC:427)
|
non-small cell lung carcinoma
(MONDO_0005233)
|
strong |
strong |
moderate |
strong |
weak |
|
|
SEC16A–NOTCH1
(HGNC:29006, HGNC:7881)
|
breast cancer
(MONDO_0007254)
|
strong |
weak |
weak |
moderate |
weak |
|
|
BEND2–MN1
(HGNC:28509, HGNC:7180)
|
MONDO:0016707
(MONDO:0016707)
|
strong |
moderate |
moderate |
strong |
moderate |
|
|
JAZF1–PHF1
(HGNC:28917, HGNC:8919)
|
endometrial stromal tumor
(MONDO_0003311)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
GLIS3–PAX8
(HGNC:28510, HGNC:8622)
|
thyroid tumor
(MONDO_0015074)
|
strong |
moderate |
weak |
strong |
weak |
|
|
BEND2–EWSR1
(HGNC:28509, HGNC:3508)
|
MONDO:0016707
(MONDO:0016707)
|
strong |
weak |
moderate |
strong |
weak |
|
|
ZFTA–RELA
(HGNC:28449, HGNC:9955)
|
MONDO:0016698
(MONDO:0016698)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
ZFTA–MRTFB
(HGNC:28449, HGNC:29819)
|
MONDO:0000977
(MONDO:0000977)
|
weak |
weak |
weak |
weak |
weak |
|
|
PHF23–NUP98
(HGNC:28428, HGNC:8068)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
PRRC2B–ALK
(HGNC:28121, HGNC:427)
|
inflammatory myofibroblastic tumor
(MONDO_0015798)
|
strong |
strong |
moderate |
strong |
weak |
|
|
DEK–NUP214
(HGNC:2768, HGNC:8064)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
moderate |
strong |
strong |
strong |
|
|
DEK–AFF2
(HGNC:2768, HGNC:3776)
|
MONDO:0006074
(MONDO:0006074)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
DDX10–NUP98
(HGNC:2735, HGNC:8068)
|
hematopoietic and lymphoid cell neoplasm
(MONDO_0044881)
|
strong |
weak |
moderate |
strong |
moderate |
|
|
DCTN1–ALK
(HGNC:2711, HGNC:427)
|
MONDO:0015798
(MONDO:0015798)
|
strong |
strong |
moderate |
strong |
weak |
|
|
DDIT3–FUS
(HGNC:2726, HGNC:4010)
|
MONDO:0013280
(MONDO:0013280)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
EWSR1–DDIT3
(HGNC:3508, HGNC:2726)
|
myxoid liposarcoma
(MONDO_0013280)
|
strong |
weak |
moderate |
moderate |
weak |
|